Concordia has adopted nine clinical practice guidelines. These guidelines have all been developed by medical specialty societies.
Guidelines adopted from the American Psychiatric Association:
- Major Depressive Disorders practice guidelines
- Substance Use Disorders practice guidelines
- Panic Disorder practice guidelines
- Bipolar Disorders practice guidelines
- Suicidal Behaviors practice guidelines
- Schizophrenia practice guidelines
Guidelines adopted from the USF Florida Medicaid Drug Therapy Management Program for Behavioral Health:
Guidelines adopted from the American Academy of Child and Adolescent Psychiatry:
- Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (Historical Parameter)
Guidelines adopted from the American Academy of Pediatrics:
Guidelines adopted from the Academy of Psychosomatic Medicine:
Clinical practice guidelines are an aid to decision-making for clinicians and their patients for specific clinical circumstances. Concordia recognizes that patients’ decisions, not just practitioner recommendations, influence the course of treatment. Because we have adopted guidelines from recognized specialty societies that we believe represent the best recommendations for treatment, we have initiated a process to measure compliance with the guidelines.
We have selected measurable characteristics from three of the guidelines.
For Major Depressive Disorder in Adults, we measure:
- The percentage of newly diagnosed and treated members who remained on an antidepressant medication for at least 84 days (12 weeks).
- The percentage of newly diagnosed and treated members who remained on an antidepressant medication for at least 180 days (6 months).
For Attention Deficit Hyperactivity Disorder, we measure:
- The percentage of members 6-12 years of age who, after receiving a new outpatient prescription for ADHD medication, had one follow-up visit with a practitioner with prescribing authority within the next 30 days.
- The percentage of members defined above who remained on the medication for at least 210 days and who, in addition to the visit in the Initiation Phase, had at least two follow-up visits with a practitioner within 270 days (9 months).
For Schizophrenia, we measure:
- The percentage of frequent readmitters who have outpatient therapy between hospitalizations.
- The percentage of members with schizophrenia who are prescribed adjunctive medications along with the anti-psychotics.